Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Colorectal+Neoplasms%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Colorectal+Neoplasms%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Colorectal+Neoplasms%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (4.654)
1
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors : Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study : Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC : Phase II Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With Metastatic Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer : AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600E-MUTANT COLORECTAL CANCER
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of ESG401 in Adults With Solid Tumors : An Open-Label, Multiple Dose, Dose Escalation and Cohort Expansion Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of ESG401 in Subjects With Locally Advanced/Metastatic Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer : A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF ENCORAFENIB AND CETUXIMAB PLUS PEMBROLIZUMAB VERSUS PEMBROLIZUMAB ALONE IN PARTICIPANTS WITH PREVIOUSLY UNTREATED BRAF V600E-MUTANT, MSI H/DMMR METASTATIC COLORECTAL CANCER
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer : A Prospective, Multicenter, Open, Randomized Controlled Phase II Clinical Study Evaluating Recombinant Oncolytic HSV2(OH2)Therapeutic Injecta(Vero Cell) for Human Use(rHSV2hGM-CSF) in Combination With Capecitabine for First-line Maintenance Therapy in Advanced Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients : the Effect of the Interactive Nurse Support Program, Developed as a Mobile Application, on Patient Outcomes in Colorectal Cancer Patients Receiving Chemotherapy During the Covid-19 Process
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer : A Phase 1 Study of ZEN003694 (ZEN-3694) in Combination With Cetuximab and Encorafenib in Patients With Refractory BRAF V600E Metastatic Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[466]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
4.654
Aufsätze
4.654
E-Artikel
4.654
E-Ressourcen
Zeitschriftentitel
4.378
ClinicalTrials.gov
276
WHO International Clinical Trials Registry Plat...
Thema
4.654
610
4.299
Colorectal Neoplasms
3.608
Study Type: Interventional
1.803
Recruitment Status: Completed
1.152
Recruitment Status: Recruiting
1.068
Phase: Phase 2
985
Study Type: Observational
831
Medical Condition: Colorectal Cancer
418
Phase: Phase 1
404
Recruitment Status: Not yet recruiting
396
Phase: Phase 3
387
Recruitment Status: Unknown status
367
Recruitment Status: Active, not recruiting
353
Neoplasms
309
Medical Condition: Metastatic Colorectal Cancer
296
Recruitment Status: Terminated
265
Neoplasm Metastasis
257
Carcinoma
202
Medical Condition: Colorectal Neoplasms
180
Phase: Phase 1, Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.848
2020-
1.701
2010-2019
105
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.648
Englisch
6
Unbestimmt
Haven't found what you're looking for?
Wird geladen...